HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages

J Leukoc Biol. 2000 Sep;68(3):366-72.

Abstract

The HIV-1 vpr gene encodes a 14-kDa virion-packaged protein that has been implicated in viral pathogenesis. Vpr exhibits profound effects on human primary cells influencing proliferation, differentiation, apoptosis, and cytokine production, in part through NF-kappaB-mediated transcription. NF-kappaB, a potent transcription factor, activates many proinflammatory cytokines/chemokines upon infection. Here, we analyzed the effect of extracellular Vpr as well as the virion-associated Vpr on beta chemokines (MIP-1alpha, MIP-1beta, and RANTES) production in human macrophages and primary lymphocytes (PBLs). Macrophages and PBLs exposed to HIV-1 vpr+ viruses or to recombinant Vpr protein produced significantly less beta chemokines compared with cells infected with HIV-1 vpr-viruses or irrelevant control protein (Gag)-exposed cells. These results suggest that a Vpr-mediated increase in virus replication could be in part through down-regulation of chemokine production.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Chemokines, CC / biosynthesis*
  • Chemokines, CC / genetics
  • Gene Expression Regulation, Viral / physiology
  • Gene Products, vpr / genetics
  • Gene Products, vpr / pharmacology
  • Gene Products, vpr / physiology*
  • Genes, vpr
  • HIV-1 / genetics*
  • HIV-1 / physiology
  • HeLa Cells
  • Humans
  • Lymphocytes / metabolism*
  • Lymphocytes / virology
  • Macrophages / metabolism*
  • Macrophages / virology
  • Recombinant Proteins / pharmacology
  • Virion / genetics
  • Virion / metabolism
  • Virus Replication / physiology
  • vpr Gene Products, Human Immunodeficiency Virus

Substances

  • Chemokines, CC
  • Gene Products, vpr
  • Recombinant Proteins
  • vpr Gene Products, Human Immunodeficiency Virus